Article in MedChemComm, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Sabin Llona-MinguezDivision of Translational Medicine and Chemical Biology , Science for Life Laboratory , Department of Medical Biochemistry and Biophysics , Karolinska Institutet , Stockholm , Sweden . Email: sabin.llona.minguez@scilifelab.se ; Email: thomas.helleday@scilifelab.se.ORCID 0000-0003-3187-722X
Artin GhassemianDivision of Translational Medicine and Chemical Biology , Science for Life Laboratory , Department of Medical Biochemistry and Biophysics , Karolinska Institutet , Stockholm , Sweden . Email: sabin.llona.minguez@scilifelab.se ; Email: thomas.helleday@scilifelab.se.
Pawel BaranczewskiUppsala University Drug Optimization and Pharmaceutical Profiling Platform (UDOPP) , Science for Life Laboratory , Department of Pharmacy , Uppsala University , Uppsala , Sweden.
Matthieu DesrosesDivision of Translational Medicine and Chemical Biology , Science for Life Laboratory , Department of Medical Biochemistry and Biophysics , Karolinska Institutet , Stockholm , Sweden . Email: sabin.llona.minguez@scilifelab.se ; Email: thomas.helleday@scilifelab.se.ORCID 0000-0003-4152-3855
Tobias KoolmeisterDivision of Translational Medicine and Chemical Biology , Science for Life Laboratory , Department of Medical Biochemistry and Biophysics , Karolinska Institutet , Stockholm , Sweden . Email: sabin.llona.minguez@scilifelab.se ; Email: thomas.helleday@scilifelab.se.
Per ArturssonUppsala University Drug Optimization and Pharmaceutical Profiling Platform (UDOPP) , Science for Life Laboratory , Department of Pharmacy , Uppsala University , Uppsala , Sweden.
Martin ScobieDivision of Translational Medicine and Chemical Biology , Science for Life Laboratory , Department of Medical Biochemistry and Biophysics , Karolinska Institutet , Stockholm , Sweden . Email: sabin.llona.minguez@scilifelab.se ; Email: thomas.helleday@scilifelab.se.
Thomas HelledayDivision of Translational Medicine and Chemical Biology , Science for Life Laboratory , Department of Medical Biochemistry and Biophysics , Karolinska Institutet , Stockholm , Sweden . Email: sabin.llona.minguez@scilifelab.se ; Email: thomas.helleday@scilifelab.se.ORCID 0000-0002-7384-092X
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
In this study, we provide insight into the metabolic profile of a series of piperazin-1-ylpyridazines suffering from rapid
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Structure-metabolism-relationships in the microsomal clearance of piperazin-1-ylpyridazines. · full record | OpenQuestion